Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Convalescent plasma has been deployed globally as a treatment for COVID-19, but efficacy has been mixed. Better understanding of the antibody characteristics that may contribute to its antiviral effects is important for this intervention as well as offer insights into correlates of vaccine-mediated...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
American Society for Microbiology
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/06bc9967a2e644a7be0d758babdbd5ad |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| id |
oai:doaj.org-article:06bc9967a2e644a7be0d758babdbd5ad |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:06bc9967a2e644a7be0d758babdbd5ad2021-11-03T18:56:09ZMarkers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma2150-751110.1128/mBio.00765-21https://doaj.org/article/06bc9967a2e644a7be0d758babdbd5ad2021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00765-21https://doaj.org/toc/2150-7511 Convalescent plasma has been deployed globally as a treatment for COVID-19, but efficacy has been mixed. Better understanding of the antibody characteristics that may contribute to its antiviral effects is important for this intervention as well as offer insights into correlates of vaccine-mediated protection.Harini NatarajanAndrew R. CrowleySavannah E. ButlerShiwei XuJoshua A. WeinerEvan M. BlochKirsten LittlefieldWendy Wieland-AlterRuth I. ConnorPeter F. WrightSarah E. BennerTania S. BonnyOliver LaeyendeckerDavid SullivanShmuel ShohamThomas C. QuinnH. Benjamin LarmanArturo CasadevallAndrew PekoszAndrew D. ReddAaron A. R. TobianMargaret E. AckermanAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 2 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Microbiology QR1-502 |
| spellingShingle |
Microbiology QR1-502 Harini Natarajan Andrew R. Crowley Savannah E. Butler Shiwei Xu Joshua A. Weiner Evan M. Bloch Kirsten Littlefield Wendy Wieland-Alter Ruth I. Connor Peter F. Wright Sarah E. Benner Tania S. Bonny Oliver Laeyendecker David Sullivan Shmuel Shoham Thomas C. Quinn H. Benjamin Larman Arturo Casadevall Andrew Pekosz Andrew D. Redd Aaron A. R. Tobian Margaret E. Ackerman Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| description |
Convalescent plasma has been deployed globally as a treatment for COVID-19, but efficacy has been mixed. Better understanding of the antibody characteristics that may contribute to its antiviral effects is important for this intervention as well as offer insights into correlates of vaccine-mediated protection. |
| format |
article |
| author |
Harini Natarajan Andrew R. Crowley Savannah E. Butler Shiwei Xu Joshua A. Weiner Evan M. Bloch Kirsten Littlefield Wendy Wieland-Alter Ruth I. Connor Peter F. Wright Sarah E. Benner Tania S. Bonny Oliver Laeyendecker David Sullivan Shmuel Shoham Thomas C. Quinn H. Benjamin Larman Arturo Casadevall Andrew Pekosz Andrew D. Redd Aaron A. R. Tobian Margaret E. Ackerman |
| author_facet |
Harini Natarajan Andrew R. Crowley Savannah E. Butler Shiwei Xu Joshua A. Weiner Evan M. Bloch Kirsten Littlefield Wendy Wieland-Alter Ruth I. Connor Peter F. Wright Sarah E. Benner Tania S. Bonny Oliver Laeyendecker David Sullivan Shmuel Shoham Thomas C. Quinn H. Benjamin Larman Arturo Casadevall Andrew Pekosz Andrew D. Redd Aaron A. R. Tobian Margaret E. Ackerman |
| author_sort |
Harini Natarajan |
| title |
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| title_short |
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| title_full |
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| title_fullStr |
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| title_full_unstemmed |
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma |
| title_sort |
markers of polyfunctional sars-cov-2 antibodies in convalescent plasma |
| publisher |
American Society for Microbiology |
| publishDate |
2021 |
| url |
https://doaj.org/article/06bc9967a2e644a7be0d758babdbd5ad |
| work_keys_str_mv |
AT harininatarajan markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT andrewrcrowley markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT savannahebutler markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT shiweixu markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT joshuaaweiner markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT evanmbloch markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT kirstenlittlefield markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT wendywielandalter markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT ruthiconnor markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT peterfwright markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT sarahebenner markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT taniasbonny markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT oliverlaeyendecker markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT davidsullivan markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT shmuelshoham markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT thomascquinn markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT hbenjaminlarman markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT arturocasadevall markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT andrewpekosz markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT andrewdredd markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT aaronartobian markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma AT margareteackerman markersofpolyfunctionalsarscov2antibodiesinconvalescentplasma |
| _version_ |
1718445436470034432 |